Results 131 to 140 of about 13,660 (185)

Monoclonal antibodies in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis. [PDF]

BMC Neurol
de Melo PS, de Oliveira Costa E, Ribeiro CMB, de Jesus PAP, Martin DLS.   +4 more
europepmc   +1 more source

Real-World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease. [PDF]

Ann Clin Transl Neurol
Lin LT, Lin HA, Lin SF.
europepmc   +1 more source

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders. [PDF]

Neurol Neuroimmunol Neuroinflamm
Niederschweiberer M, Panagiotaropoulou G, Fernandez-Viña MA, Montero-Martin G, Osoegawa K, Behne M, Franke A, Lieb W, Jarius S, Wildemann B, Schindler P, Otto C, Paul F, Flanagan EP, Cook LJ, Oksenberg J, Yeaman MR, Ripke S, Ruprecht K, Guthy-Jackson Charitable Foundation CIRCLES Study Group.   +19 more
europepmc   +1 more source

Case Report: Neuromyelitis optica spectrum disorder associated with gastric cardia and pancreatic cancers: clinical features and oncological implications. [PDF]

Front Oncol
Wei X, Yuan K, Sang W, Zhang H, Qin Y.
europepmc   +1 more source

Longitudinal retinal microvascular changes and their association with white matter hyperintensities in neuromyelitis optica spectrum disorder. [PDF]

Front Neurol
Liu Y, Xu S, Lin H, Lei X, Li Y, Xu Z, Wei R, Jiang HR, Mei J.   +8 more
europepmc   +1 more source

Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series. [PDF]

Front Immunol
Deng M, Chen L, Chen W, Zeng K, Yao Y, Chen H, Lin A.   +6 more
europepmc   +1 more source

Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany. [PDF]

Neurol Res Pract
Giglhuber K, Bertrand A, Zappe C, Kleiter I, Ayzenberg I, Berthele A, Neuromyelitis Optica Study Group (NEMOS).   +6 more
europepmc   +1 more source

Integrated Blood Inflammatory Ratios and Cerebrospinal Fluid Blood‒Brain Barrier Dysfunction Predict Relapse Risk in Neuromyelitis Optica Spectrum Disorder. [PDF]

Brain Behav
Zheng X, Shi J, Yin H, Song H, Zhai Q, Si C, Chen J, Li P, Zhang L, Li Y, Dong C, Liu H.   +11 more
europepmc   +1 more source

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review. [PDF]

Curr Neurol Neurosci Rep
Zhang X, Kattah JC.
europepmc   +1 more source